vs
Side-by-side financial comparison of ARGENX SE (ARGX) and Huntington Ingalls Industries (HII). Click either name above to swap in a different company.
ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $1.7B, roughly 1.5× Huntington Ingalls Industries). ARGENX SE runs the higher net margin — 35.5% vs 8.9%, a 26.5% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 13.8%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $-461.0M).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Huntington Ingalls Industries, Inc. (HII) is the largest military shipbuilding company in the United States as well as a provider of professional services to partners in government and industry. HII was formed on 31 March 2011, as a divestiture from Northrop Grumman.
ARGX vs HII — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $1.7B |
| Net Profit | $877.2M | $149.0M |
| Gross Margin | 89.5% | — |
| Operating Margin | 28.9% | 9.3% |
| Net Margin | 35.5% | 8.9% |
| Revenue YoY | 83.2% | 13.8% |
| Net Profit YoY | 1.3% | — |
| EPS (diluted) | $13.25 | $3.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.7B | ||
| Q4 25 | $2.5B | $3.5B | ||
| Q3 25 | — | $3.2B | ||
| Q2 25 | $1.8B | $3.1B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | $1.4B | $3.0B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | $901.9M | $3.0B |
| Q1 26 | — | $149.0M | ||
| Q4 25 | $877.2M | $159.0M | ||
| Q3 25 | — | $145.0M | ||
| Q2 25 | $414.8M | $152.0M | ||
| Q1 25 | — | $149.0M | ||
| Q4 24 | $865.6M | $123.0M | ||
| Q3 24 | — | $101.0M | ||
| Q2 24 | $-32.5M | $173.0M |
| Q1 26 | — | — | ||
| Q4 25 | 89.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 89.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 90.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 89.4% | — |
| Q1 26 | — | 9.3% | ||
| Q4 25 | 28.9% | 4.9% | ||
| Q3 25 | — | 5.0% | ||
| Q2 25 | 19.2% | 5.3% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | 8.7% | 3.7% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | -15.4% | 6.3% |
| Q1 26 | — | 8.9% | ||
| Q4 25 | 35.5% | 4.6% | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | 23.4% | 4.9% | ||
| Q1 25 | — | 5.4% | ||
| Q4 24 | 64.1% | 4.1% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | -3.6% | 5.8% |
| Q1 26 | — | $3.79 | ||
| Q4 25 | $13.25 | $4.06 | ||
| Q3 25 | — | $3.68 | ||
| Q2 25 | $6.32 | $3.86 | ||
| Q1 25 | — | $3.79 | ||
| Q4 24 | $13.33 | $3.15 | ||
| Q3 24 | — | $2.56 | ||
| Q2 24 | $-0.55 | $4.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $216.0M |
| Total DebtLower is stronger | — | $2.7B |
| Stockholders' EquityBook value | $7.3B | $5.1B |
| Total Assets | $8.7B | $12.5B |
| Debt / EquityLower = less leverage | — | 0.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $216.0M | ||
| Q4 25 | $3.5B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.4B | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | $11.0M | — |
| Q1 26 | — | $5.1B | ||
| Q4 25 | $7.3B | $5.1B | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | $6.1B | $4.9B | ||
| Q1 25 | — | $4.8B | ||
| Q4 24 | $5.5B | $4.7B | ||
| Q3 24 | — | $4.2B | ||
| Q2 24 | $4.3B | $4.2B |
| Q1 26 | — | $12.5B | ||
| Q4 25 | $8.7B | $12.7B | ||
| Q3 25 | — | $12.3B | ||
| Q2 25 | $7.2B | $12.1B | ||
| Q1 25 | — | $12.1B | ||
| Q4 24 | $6.2B | $12.1B | ||
| Q3 24 | — | $11.1B | ||
| Q2 24 | $4.8B | $11.3B |
| Q1 26 | — | 0.52× | ||
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | $-390.0M |
| Free Cash FlowOCF − Capex | $322.4M | $-461.0M |
| FCF MarginFCF / Revenue | 13.0% | -27.7% |
| Capex IntensityCapex / Revenue | 0.0% | 4.4% |
| Cash ConversionOCF / Net Profit | 0.37× | -2.62× |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | $795.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-390.0M | ||
| Q4 25 | $323.3M | $650.0M | ||
| Q3 25 | — | $118.0M | ||
| Q2 25 | $361.8M | $823.0M | ||
| Q1 25 | — | $-395.0M | ||
| Q4 24 | $41.9M | $391.0M | ||
| Q3 24 | — | $213.0M | ||
| Q2 24 | $-124.7M | $-9.0M |
| Q1 26 | — | $-461.0M | ||
| Q4 25 | $322.4M | $516.0M | ||
| Q3 25 | — | $13.0M | ||
| Q2 25 | $356.6M | $727.0M | ||
| Q1 25 | — | $-462.0M | ||
| Q4 24 | $40.9M | $277.0M | ||
| Q3 24 | — | $125.0M | ||
| Q2 24 | $-125.5M | $-99.0M |
| Q1 26 | — | -27.7% | ||
| Q4 25 | 13.0% | 14.8% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | 20.1% | 23.6% | ||
| Q1 25 | — | -16.9% | ||
| Q4 24 | 3.0% | 9.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | -13.9% | -3.3% |
| Q1 26 | — | 4.4% | ||
| Q4 25 | 0.0% | 3.9% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | 0.3% | 3.1% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | 0.1% | 3.8% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | 0.1% | 3.0% |
| Q1 26 | — | -2.62× | ||
| Q4 25 | 0.37× | 4.09× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | 0.87× | 5.41× | ||
| Q1 25 | — | -2.65× | ||
| Q4 24 | 0.05× | 3.18× | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | — | -0.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
